Jane Street
TVTX icon

Jane Street’s Travere Therapeutics TVTX Stock Holding History

Jane Street’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Buy
305,100
+256,600
+529% +$11.4M ﹤0.01% 2275
2026
Q1 		$1.44M Buy
48,500
+7,400
+18% +$221K ﹤0.01% 5727
2025
Q4 		$1.57M Sell
41,100
-27,800
-40% -$904K ﹤0.01% 5258
2025
Q3 		$1.65M Buy
+68,900
New +$1.3M ﹤0.01% 5298
2025
Q2 		– Sell
-413,700
Closed -$7.41M – 10930
2025
Q1 		$7.41M Sell
413,700
-132,900
-24% -$2.7M ﹤0.01% 2372
2024
Q4 		$9.52M Sell
546,600
-7,100
-1% -$126K ﹤0.01% 1931
2024
Q3 		$7.75M Buy
553,700
+369,600
+201% +$3.85M ﹤0.01% 2219
2024
Q2 		$1.51M Sell
184,100
-159,100
-46% -$1.07M ﹤0.01% 4988
2024
Q1 		$2.65M Buy
343,200
+15,500
+5% +$131K ﹤0.01% 3620
2023
Q4 		$2.95M Buy
327,700
+257,800
+369% +$1.88M ﹤0.01% 3668
2023
Q3 		$625K Buy
69,900
+32,300
+86% +$456K ﹤0.01% 5930
2023
Q2 		$578K Buy
+37,600
New +$684K ﹤0.01% 6100
2022
Q2 		– Sell
-9,100
Closed -$235K – 10914
2022
Q1 		$235K Buy
9,100
+2,600
+40% +$69K ﹤0.01% 8792
2021
Q4 		$202K Buy
+6,500
New +$183K ﹤0.01% 8809
2021
Q3 		– Sell
-13,800
Closed -$201K – 10751
2021
Q2 		$201K Buy
+13,800
New +$272K ﹤0.01% 8818
2019
Q4 		– Sell
-10,400
Closed -$121K – 5767
2019
Q3 		$121K Buy
+10,400
New +$172K ﹤0.01% 4766
2015
Q3 		– Sell
-17,900
Closed -$593K – 4160
2015
Q2 		$593K Buy
+17,900
New +$490K ﹤0.01% 2110

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's TVTX Position: Q2 2026 in Review

Jane Street increased its Travere Therapeutics (TVTX) stake by 211% in Q2 2026, buying an estimated $28.2M and bringing the position to 938,699 shares worth $53.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1371.

Jane Street first reported a position in TVTX in Q1 2014 and has held it in 26 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Jane Street held 938,699 shares of Travere Therapeutics worth $53.3M as of Q2 2026.
  • Jane Street bought 636,419 Travere Therapeutics shares in Q2 2026, an estimated $28.2M.
  • Travere Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1371 holding.
  • Jane Street first reported a position in Travere Therapeutics in Q1 2014 and has held it in 26 quarters since.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.